Research output per year
Research output per year
Personal profile
Research interests
I am interested in developing and assessing new techniques using ultrasound in the evaluation and assessment of neuromuscular disorders.
Clinical interests
Adult and pediatric neurology, neuromuscular disease.
Fingerprint
Dive into the research topics where Craig Zaidman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy
Waldrop, M. A., Moore, S. A., Mathews, K. D., Darbro, B. W., Medne, L., Finkel, R., Connolly, A. M., Crawford, T. O., Drachman, D., Wein, N., Habib, A. A., Krzesniak-Swinarska, M. A., Zaidman, C. M., Collins, J. J., Jokela, M., Udd, B., Day, J. W., Ortiz-Guerrero, G., Statland, J., Butterfield, R. J., & 3 others, Apr 2022, In: Human mutation. 43, 4, p. 511-528 18 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
Clemens, P. R., Rao, V. K., Connolly, A. M., Harper, A. D., Mah, J. K., McDonald, C. M., Smith, E. C., Zaidman, C. M., Nakagawa, T. & Hoffman, E. P., 2022, In: Journal of neuromuscular diseases. 9, 4, p. 493-501 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
Strauss, K. A., Farrar, M. A., Muntoni, F., Saito, K., Mendell, J. R., Servais, L., McMillan, H. J., Finkel, R. S., Swoboda, K. J., Kwon, J. M., Zaidman, C. M., Chiriboga, C. A., Iannaccone, S. T., Krueger, J. M., Parsons, J. A., Shieh, P. B., Kavanagh, S., Wigderson, M., Tauscher-Wisniewski, S., McGill, B. E., & 1 others, Jul 2022, In: Nature medicine. 28, 7, p. 1390-1397 8 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
Strauss, K. A., Farrar, M. A., Muntoni, F., Saito, K., Mendell, J. R., Servais, L., McMillan, H. J., Finkel, R. S., Swoboda, K. J., Kwon, J. M., Zaidman, C. M., Chiriboga, C. A., Iannaccone, S. T., Krueger, J. M., Parsons, J. A., Shieh, P. B., Kavanagh, S., Tauscher-Wisniewski, S., McGill, B. E. & Macek, T. A., Jul 2022, In: Nature medicine. 28, 7, p. 1381-1389 9 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Laboratory monitoring of nusinersen safety
Goedeker, N. L., Gibbons, J. L., Varadhachary, A. S., Connolly, A. M. & Zaidman, C. M., Jun 2021, In: Muscle and Nerve. 63, 6, p. 902-905 4 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations